mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Authors:
- 28 October 2013
- journal article
- review article
- Published by Springer Nature in Nature Neuroscience
- Vol. 16 (11) , 1537-1543
Abstract
The mechanistic target of rapamycin (mTOR) acts as a highly conserved signaling “hub” that integrates neuronal activity and a variety of synaptic inputs. mTOR is found in two functionally distinct complexes, mTORC1 and mTORC2, that crucially control long-term synaptic efficacy and memory storage. Dysregulation of mTOR signaling is associated with neurodevelopmental and neuropsychiatric disorders. In this Review, we describe the most recent advances in studies of mTOR signaling in the brain and the possible mechanisms underlying the many different functions of the mTOR complexes in neurological diseases. In addition, we discuss the medical relevance of these findings.Keywords
This publication has 102 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Interplay between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for SchizophreniaCell, 2012
- Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycinNeurobiology of Disease, 2012
- Role for mTOR Signaling and Neuronal Activity in Morphine-Induced Adaptations in Ventral Tegmental Area Dopamine NeuronsNeuron, 2011
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and AutismCell, 2011
- Postnatal Deamidation of 4E-BP2 in Brain Enhances Its Association with Raptor and Alters Kinetics of Excitatory Synaptic TransmissionMolecular Cell, 2010
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their SurvivalCell, 2009
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological TargetsCell, 2009
- Neurofibromin Regulation of ERK Signaling Modulates GABA Release and LearningCell, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008